NRDN-101

N/A

Report date: 2025/07/03 16:42:42
NME

Base Information

Drug NameNRDN-101
Drug Alias NameNDC-0009NRDN-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic reticulum calcium-transporting ATPases stimulants
TargetsSarcoplasmic reticulum calcium-transporting ATPases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurodon Corp
China Registration ClassN/A

Develop Information

Active CompaniesNeurodon Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A